La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.

Identifieur interne : 001653 ( PubMed/Corpus ); précédent : 001652; suivant : 001654

Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.

Auteurs : P. Horellou ; E. Vigne ; M N Castel ; P. Barnéoud ; P. Colin ; M. Perricaudet ; P. Delaère ; J. Mallet

Source :

RBID : pubmed:7703427

English descriptors

Abstract

Direct intracerebral gene transfer to neural cells has been demonstrated with recombinant adenovirus encoding beta-galactosidase. To explore the potential of recombinant adenovirus for the therapy of neurological disease we constructed a recombinant adenovirus encoding tyrosine hydroxylase and optimized intracerebral injection to express the gene in the striatum of unilaterally denervated rats. These animals have dopamine depletion in their lesioned striatum, causing a rotation asymmetry induced by apomorphine. One and two weeks after intracerebral injection this sensorimotor asymmetry was decreased by the adenovirus encoding tyrosine hydroxylase and not by a control adenovirus encoding beta-galactosidase. Histological analysis showed that tyrosine hydroxylase was preferentially expressed in astrocytes.

PubMed: 7703427

Links to Exploration step

pubmed:7703427

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.</title>
<author>
<name sortKey="Horellou, P" sort="Horellou, P" uniqKey="Horellou P" first="P" last="Horellou">P. Horellou</name>
<affiliation>
<nlm:affiliation>C 9923 CNRS, Laboratoire de Génétique Moléculaire de la Neurotransmission et des Processus Dégénératifs, Gif-sur-Yvette, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vigne, E" sort="Vigne, E" uniqKey="Vigne E" first="E" last="Vigne">E. Vigne</name>
</author>
<author>
<name sortKey="Castel, M N" sort="Castel, M N" uniqKey="Castel M" first="M N" last="Castel">M N Castel</name>
</author>
<author>
<name sortKey="Barneoud, P" sort="Barneoud, P" uniqKey="Barneoud P" first="P" last="Barnéoud">P. Barnéoud</name>
</author>
<author>
<name sortKey="Colin, P" sort="Colin, P" uniqKey="Colin P" first="P" last="Colin">P. Colin</name>
</author>
<author>
<name sortKey="Perricaudet, M" sort="Perricaudet, M" uniqKey="Perricaudet M" first="M" last="Perricaudet">M. Perricaudet</name>
</author>
<author>
<name sortKey="Delaere, P" sort="Delaere, P" uniqKey="Delaere P" first="P" last="Delaère">P. Delaère</name>
</author>
<author>
<name sortKey="Mallet, J" sort="Mallet, J" uniqKey="Mallet J" first="J" last="Mallet">J. Mallet</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7703427</idno>
<idno type="pmid">7703427</idno>
<idno type="wicri:Area/PubMed/Corpus">001653</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001653</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.</title>
<author>
<name sortKey="Horellou, P" sort="Horellou, P" uniqKey="Horellou P" first="P" last="Horellou">P. Horellou</name>
<affiliation>
<nlm:affiliation>C 9923 CNRS, Laboratoire de Génétique Moléculaire de la Neurotransmission et des Processus Dégénératifs, Gif-sur-Yvette, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vigne, E" sort="Vigne, E" uniqKey="Vigne E" first="E" last="Vigne">E. Vigne</name>
</author>
<author>
<name sortKey="Castel, M N" sort="Castel, M N" uniqKey="Castel M" first="M N" last="Castel">M N Castel</name>
</author>
<author>
<name sortKey="Barneoud, P" sort="Barneoud, P" uniqKey="Barneoud P" first="P" last="Barnéoud">P. Barnéoud</name>
</author>
<author>
<name sortKey="Colin, P" sort="Colin, P" uniqKey="Colin P" first="P" last="Colin">P. Colin</name>
</author>
<author>
<name sortKey="Perricaudet, M" sort="Perricaudet, M" uniqKey="Perricaudet M" first="M" last="Perricaudet">M. Perricaudet</name>
</author>
<author>
<name sortKey="Delaere, P" sort="Delaere, P" uniqKey="Delaere P" first="P" last="Delaère">P. Delaère</name>
</author>
<author>
<name sortKey="Mallet, J" sort="Mallet, J" uniqKey="Mallet J" first="J" last="Mallet">J. Mallet</name>
</author>
</analytic>
<series>
<title level="j">Neuroreport</title>
<idno type="ISSN">0959-4965</idno>
<imprint>
<date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenoviridae (physiology)</term>
<term>Animals</term>
<term>Apomorphine (pharmacology)</term>
<term>Behavior, Animal (drug effects)</term>
<term>Brain (physiopathology)</term>
<term>Corpus Striatum (drug effects)</term>
<term>Denervation</term>
<term>Female</term>
<term>Gene Transfer Techniques</term>
<term>Genetic Vectors</term>
<term>Oxidopamine (pharmacology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (therapy)</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
<term>Recombination, Genetic</term>
<term>Stereotyped Behavior</term>
<term>Tyrosine 3-Monooxygenase (genetics)</term>
<term>beta-Galactosidase (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Tyrosine 3-Monooxygenase</term>
<term>beta-Galactosidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Apomorphine</term>
<term>Oxidopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Behavior, Animal</term>
<term>Corpus Striatum</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Adenoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Denervation</term>
<term>Female</term>
<term>Gene Transfer Techniques</term>
<term>Genetic Vectors</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
<term>Recombination, Genetic</term>
<term>Stereotyped Behavior</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Direct intracerebral gene transfer to neural cells has been demonstrated with recombinant adenovirus encoding beta-galactosidase. To explore the potential of recombinant adenovirus for the therapy of neurological disease we constructed a recombinant adenovirus encoding tyrosine hydroxylase and optimized intracerebral injection to express the gene in the striatum of unilaterally denervated rats. These animals have dopamine depletion in their lesioned striatum, causing a rotation asymmetry induced by apomorphine. One and two weeks after intracerebral injection this sensorimotor asymmetry was decreased by the adenovirus encoding tyrosine hydroxylase and not by a control adenovirus encoding beta-galactosidase. Histological analysis showed that tyrosine hydroxylase was preferentially expressed in astrocytes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">7703427</PMID>
<DateCreated>
<Year>1995</Year>
<Month>05</Month>
<Day>09</Day>
</DateCreated>
<DateCompleted>
<Year>1995</Year>
<Month>05</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0959-4965</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1994</Year>
<Month>Dec</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Neuroreport</Title>
<ISOAbbreviation>Neuroreport</ISOAbbreviation>
</Journal>
<ArticleTitle>Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>49-53</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Direct intracerebral gene transfer to neural cells has been demonstrated with recombinant adenovirus encoding beta-galactosidase. To explore the potential of recombinant adenovirus for the therapy of neurological disease we constructed a recombinant adenovirus encoding tyrosine hydroxylase and optimized intracerebral injection to express the gene in the striatum of unilaterally denervated rats. These animals have dopamine depletion in their lesioned striatum, causing a rotation asymmetry induced by apomorphine. One and two weeks after intracerebral injection this sensorimotor asymmetry was decreased by the adenovirus encoding tyrosine hydroxylase and not by a control adenovirus encoding beta-galactosidase. Histological analysis showed that tyrosine hydroxylase was preferentially expressed in astrocytes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Horellou</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>C 9923 CNRS, Laboratoire de Génétique Moléculaire de la Neurotransmission et des Processus Dégénératifs, Gif-sur-Yvette, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vigne</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Castel</LastName>
<ForeName>M N</ForeName>
<Initials>MN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barnéoud</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Colin</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Perricaudet</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Delaère</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mallet</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Neuroreport</MedlineTA>
<NlmUniqueID>9100935</NlmUniqueID>
<ISSNLinking>0959-4965</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>8HW4YBZ748</RegistryNumber>
<NameOfSubstance UI="D016627">Oxidopamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.16.2</RegistryNumber>
<NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.23</RegistryNumber>
<NameOfSubstance UI="D001616">beta-Galactosidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>N21FAR7B4S</RegistryNumber>
<NameOfSubstance UI="D001058">Apomorphine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001058" MajorTopicYN="N">Apomorphine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003714" MajorTopicYN="N">Denervation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018014" MajorTopicYN="Y">Gene Transfer Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016627" MajorTopicYN="N">Oxidopamine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011995" MajorTopicYN="N">Recombination, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013239" MajorTopicYN="N">Stereotyped Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001616" MajorTopicYN="N">beta-Galactosidase</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1994</Year>
<Month>12</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1994</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1994</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">7703427</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001653 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001653 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:7703427
   |texte=   Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:7703427" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024